Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells
Chun‐Han Chen(Wan Fang Hospital), Yun Yen(City Of Hope National Medical Center)
Cited by 20
Related Papers
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
|Journal of Hematology & Oncology|2017|153